PROSTATYPE GENOMICS AB revenue for the last year amounted to 1.03 M SEK, the most of which — 1.36 M SEK — came from its highest performing source at the moment, Prognostic Gene Test, the year earlier bringing 682.80 k SEK. The greatest contribution to the revenue figure was made by Europe — last year it brought PROSTATYPE GENOMICS AB 601.00 k SEK.